Quantcast
Tag archive for ‘orphan drug’
By The Dispatch On Saturday, December 17th, 2016
0 Comments

Profounda receives FDA Orphan Drug Designation for miltefosine for treating Primary Amebic Meningoencephalitis (PAM)

Profounda, Inc. announced Friday that it has received, the US Food and Drug Administration’s (FDA) Orphan Drug Designation for the treatment of Primary Amebic Meningoencephalitis (PAM) with miltefosine.  More...

By Robert Herriman On Monday, December 31st, 2012
1 Comment

Janssen Therapeutic’s ‘Sirturo’ receives FDA approval for treatment of multi-drug resistant pulmonary tuberculosis

This is an anteroposterior (AP) x-ray of a patient’s chest, who was diagnosed with bilateral pulmonary tuberculosis. Image/CDC In a follow-up to a Dec. 1 story, Janssen Therapeutics has announced the U.S. More...

By Robert Herriman On Wednesday, December 26th, 2012
2 Comments

Orphan drug, Juxtapid gets FDA approval for treating HoFH

The US Food and Drug Administration announced the approval of Juxtapid (lomitapide), a new orphan drug used to reduce cholesterol in patients with the rare disorder, homozygous familial hypercholesterolemia (HoFH), More...


Recent Posts

January 20, 2021, Comments Off on

January 20, 2021, Comments Off on

January 20, 2021, Comments Off on

January 20, 2021, Comments Off on

January 20, 2021, Comments Off on

January 20, 2021, Comments Off on

January 19, 2021, Comments Off on

DISPATCH BLOGS

Splash Page logo 300x146 Today in History